Abstract

IntroductionControversy regarding optimum duration of trastuzumab treatment remains in patients with human epidermal growth factor receptor-2 (HER2) positive early breast cancer. The objective of applying network meta-analysis (NMA) is to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.
Peter Dall ... Ursula Cirrincione
The Oncologist | VOL. 22
Peter Dall, et. al.Peter Dall ... Ursula Cirrincione
01 Feb 2017
Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
Xavier Pivot ... Yaroslav Shparyk
Journal of Clinical Oncology | VOL. 36
Xavier Pivot, et. al.Xavier Pivot ... Yaroslav Shparyk
26 Jan 2018
Body Mass Index As A Prognostic Factor In HER-2 Positive Early Breast Cancer Patients And Its Effect On Duration Of Treatment With Trastuzumab: A Retrospective Study.
Samaa Abdalla Bardisi ... Yousra Dorgham
Journal of the Pakistan Medical Association | VOL. 73(Suppl 4)
Samaa Abdalla Bardisi, et. al. Samaa Abdalla Bardisi ... Yousra Dorgham
25 May 2023
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
...
European Journal of Cancer | VOL. 82
, et. al. ...
16 Jun 2017
View more papers

More From: BMJ open

Paper Title
Journal
Date
Author
Job satisfaction and psychosocial factors and their association with job performance in Iranian midwives: a cross-sectional study
Sepideh Mashayekh-Amiri ... Mojgan Mirghafourvand
BMJ Open | VOL. 14
Sepideh Mashayekh-Amiri, et. al.Sepideh Mashayekh-Amiri ... Mojgan Mirghafourvand
06 Aug 2024
Evaluating the impact of a ward environment with 20 single occupancy rooms and two four-bedded bays on patient and staff experiences and outcomes in an acute NHS Trust: a mixed-methods study protocol
Yetunde Ataiyero ... Sarahjane Jones
BMJ Open | VOL. 14
Yetunde Ataiyero, et. al.Yetunde Ataiyero ... Sarahjane Jones
06 Aug 2024
Prevalence, determinants and care-seeking behaviour for anxiety and depression in Nepalese population: a secondary analysis of data from Nepal Demographic and Health Survey 2022
Achyut Raj Pandey ... Sushil Baral
BMJ Open | VOL. 14
Achyut Raj Pandey, et. al.Achyut Raj Pandey ... Sushil Baral
06 Aug 2024
Role of men in women’s health service utilisation in northern Nigeria: a qualitative study of women, men and provider perspectives
Irit Sinai ... Saba Waseem
BMJ Open | VOL. 14
Irit Sinai, et. al.Irit Sinai ... Saba Waseem
06 Aug 2024
View more papers